Novel Psychoactive Substances

Classification, Pharmacology and Toxicology
Herausgeber: Dargan, Paul I; Wood, David M

• Gebundenes Buch

Produktbeschreibung

Novel Psychoactive Substances: Classification, Pharmacology and Toxicology, Second Edition provides readers with a comprehensive examination on the classification, detection, supply and availability of novel psychoactive substances, otherwise known as "legal highs." The book covers individual classes of novel psychoactive substances that have recently emerged onto the recreational drug scene and provides an overview of the pharmacology of the substance and a discussion of their associated acute and chronic harm and toxicity. This second edition addresses drugs new to the scene, with completely updated and revised chapters. Written by international experts in the field, this multi-authored book is an essential reference for scientists, clinicians, academics, and regulatory and law enforcement professionals.

Produktdetails

• Verlag: Elsevier Science
• 2nd edition
• Seitenzahl: 554
• Erscheinungstermin: 9. September 2021
• Englisch
• Abmessung: 239mm x 196mm x 32mm
• Gewicht: 1310g
• ISBN-13: 9780128187883
• ISBN-10: 0128187883
• Artikelnr.: 60182591

Inhaltsangabe

I. Background
1. Legal Classification and International Systems for Monitoring Novel
Psychoactive Substances
2. Availability and Supply of Novel Psychoactive Substances
3. Prevalence of Use of Novel Psychoactive Substances
4. Pharmacological Profiling of Novel Psychoactive Substances
5. Novel methods of NPS detection and data triangulation
6. Social issues in the use of novel psychoactive substances
7. General management of the patient with Novel Psychoactive Substance
Toxicity
8. Addiction and treatment of Novel Psychoactive Substance dependence
II. Analytical Techniques
9. Analytical techniques for the detection of novel psychoactive substances
and their metabolites
III. Individual Novel Psychoactive Substances
10. Synthetic Amphetamines including novel MDMA analogues
11. Pharmacology and Toxicology of N-Benzyl-phenylethylamines (25X-NBOMe)
Hallucinogens
12. 1-Benzylpiperazine and other Piperazine-based stimulants
13. Cathinones
14. Arylcyclohexamines
15. Synthetic cannabinoids
16. Novel opioids
17. Novel benzodiazepines
18. Tryptamines